A trusted partner in bringing new medicines to life. Fast.
Whether you are a niche biotech firm or large pharma company, we provide services spanning the entire molecular life cycle to accelerate your time to market.
Sai Life Sciences
Sai Life Sciences is the fastest-growing contract research, development, and manufacturing organisation (CRDMO) among listed Indian peers (in terms of revenue CAGR and EBITDA CAGR from FY22 to FY24). As a pure-play, full-service CRDMO, we work with over 280 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes.
Over the past 25 years, Sai Life Sciences has served diverse programmes, consistently delivering value based on its quality and responsiveness. As of March 2024, we had 2845 employees across our facilities in India, the UK, the USA and Japan.
News
Exploring climate, water, plastic pollution & related stories: A fireside chat with ISB Prof. Anjal Prakash
To mark World Environment Day, Sai Life Sciences hosted an engaging fireside chat on June 6, 2025, with Dr. Anjal Prakash, Clinical Associate Professor at ISB and lead author on multiple IPCC reports. The session was designed not just to raise awareness but to spark deeper conversations around sustainability, public policy, and climate resilience. In […]
Read more
News
Sai Life Sciences’ Peptide Research Center gets featured in Lab Design News
Sai Life Sciences’ newly launched Peptide Research Center was featured in Lab Design News, offering insights into the design philosophy and intent behind the facility. The article showcases how the center brings together synthesis, purification, and conjugation under one roof, with a layout optimized for high-throughput workflows and seamless cross-functional collaboration. The feature also spotlighted […]
Read more
News
Innovator companies prefer to work with integrated partners: Krishna Kanumuri
In a recent interview with Global Business Reports, Krishna Kanumuri, CEO and Managing Director of Sai Life Sciences, highlighted a growing industry trend: innovator companies are increasingly seeking integrated partners who can support them seamlessly from discovery through development and manufacturing. As an end-to-end CRDMO in India, Sai Life Sciences is well-positioned to meet this […]
Read more
News
Sai Life Sciences Limited reports robust FY25 results
Revenue grows by 16%; Net Profit up 105% year-on-year Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, ContractResearch, Development and Manufacturing Organization (CRDMO) announced its financial results for the fourth quarter and full year ended March 31, 2025. Financial Performance: Particulars (₹ crores) FY25 FY24 YoY% Q4FY25 Q4FY24 YoY% Revenue from […]
Read more
News
Sai Life Sciences wins Gold at CII Southern Region Awards
Sai Life Sciences has been honored with two Gold Awards at the CII Southern Region EHS Excellence Awards 2024, recognizing the company’s exemplary Environment, Health and Safety (EHS) initiatives across its sites in India. While the Integrated R&D Centre, Hyderabad, won Gold Award for EHS Excellence & Sector 2nd Topper in Pharmaceuticals & Healthcare, the […]
Read more
News
Sai Life Sciences certified as a Great Place To Work
Sai Life Sciences has been officially certified as a Great Place To Work for 2025–26, a recognition based on feedback from its employees.The certification reflects the company’s culture and the experiences of its people, with positive responses in key areas such as Corporate Brand Image, Competence, Pride, Team, and Leadership Behaviour. Together, these highlight the […]
Read more
News
Sai Life Sciences inks agreement with DHL Express to make logistics operations greener
Sai Life Sciences has inked an agreement with DHL Express to adopt its emission-reduced shipping solution — GoGreen Plus (GGP) — for its international logistics operations.To formalize the partnership, Sivaramakrishnan Chittor, CFO, Sai Life Sciences, signed an agreement with R.S. Subramanian, Senior Vice President – South Asia, DHL Express, on April 21, 2025.This collaboration will […]
Read more
News
Sai Life Sciences sets up Peptide Research Center in India
Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), has inaugurated a dedicated Peptide Research Center at its integrated R&D Campus in Hyderabad, India.Announcing the launch, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said: “As the pharmaceutical industry evolves from small molecules to […]
Read more
News
Sai Life Sciences Limited reports robust quarterly results
Revenue grows by 15%; Net Profit up 36% year-on-year Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research and Development Organization (CRDMO) today announced its financial results for the third quarter and nine months ended December 31, 2024. Financial Performance: Particulars (₹ crores) Q3FY25 Q3FY24 YoY% 9MFY25 9MFY24 YoY% Revenue […]
Read more
News
Sai Life Sciences completes restoration of historic Manchirevula stepwell
As part of its Corporate Social Responsibility (CSR) initiative, Sai Life Sciences, in collaboration with the Society for Advancement of Human Endeavours (SAHE), completed the restoration of the historic stepwell dating back to the 17th century at the Sri Venugopala Swamy temple premises, located in Manchirevula, Hyderabad. The Manchirevula Stepwell Restoration Project was undertaken with […]
Read more
News
Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) for its R&D (Unit II, Hyderabad), and Manufacturing (Unit IV, Bidar) sites in India. The General Good Manufacturing Practices (GMP) audit was conducted at the […]
Read more
News
Sai Life Sciences releases Sustainability Report 2024
Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its Sustainability Report for 2023-2024. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, this fifth edition of the Sustainability Report is based on the theme, ‘Synergising Sustainability, Performance and Growth.’ The full report can be read here. Making […]
Read more
Service
Chemistry, Manufacturing and Controls
For 25 years, we have consistently delivered on a diverse set of NCE development programs for our customers with a track record of bringing value based on quality, pricing and responsiveness. With a strong team of scientists and process engineers, we are up to any challenge involving complex chemical synthesis from route scouting, process development, scale-up to commercial scale. We make high quality APIs and intermediates that serve the highly regulated markets of USA, Europe and Japan. Our world-class manufacturing facilities are equipped with flexible and versatile infrastructure, tailored to fit the smaller volume but more complex chemistry coming out of the development pipelines today. And we are continuously investing in making it better.
Read more
Service
Discovery
Sai Life Sciences has been a trusted small molecule CRO partner helping innovator biotech and pharma companies accelerate their drug discovery journey from HIT to IND using creative chemistry supported by high-quality Biology, DMPK, toxicology and cGMP scale-up services.
We are known to be responsive, flexible and cost-effective in delivering solutions tailored to program requirements. As a testimony to our efforts, we have built strong relationships with clients spanning diverse therapeutic areas. Our strong and growing scientific team provides a "fully-integrated" service, bringing various teams' collective expertise together to develop a lead candidate.
Read more
Careers
Sai Life Sciences is the perfect workplace for ambitious individuals looking for a rewarding career within biology, chemistry and development of the medicines of tomorrow. Explore our open positions on the careers site and join our family of 2800+ strong Saimer family. We are always looking for new talent.
Read more
Facilities
Our R&D and manufacturing facilities located in US, UK and India are built to global standards and cater to an international set of clients. Several new facilities are planned for the near future and existing ones are expanding with state-of-the-art blocks. Our headquarters are in Hyderabad, right in the middle of India. We pride ourselves in a global reach.
Read more
News
Sai Life Sciences elevates Compound Management process with in-house software application, CORAL
Compound management is a vital function in pharmaceutical research. A streamlined environment can bring significant value to the process in the form of productivity and efficiency. Recognizing the importance of this function, we have made our Compound Management suite for Discovery services smarter with the introduction of an in-house software application, Compound Organization and Registration […]
Read more
News
Sai Life Sciences inducts 96 trainees across campuses in India
“I just got my first pair of safety shoes and I’m thrilled! Exploring the facility for the first time is such a joy!” – Spurthi R, Trainee, Medicinal Chemistry, Shamirpet. Ushering in a season of new beginnings, we welcomed 96 trainees across our campuses in India. These young individuals have been selected from eight colleges […]
Read more
News
Sai Life Sciences releases its Sustainability Report 2023
Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability […]
Read more
News
Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations
To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), has expanded its DMPK capabilities. The expansion comprises the addition of 25,000 sq. ft. of state-of-the-art labs equipped with cutting-edge instrumentation enabling high-end automation. Complementing the expansion has been […]
Read more